Product news

Share this article:

Xanodyne Pharmaceuticals has received an approvable letter from the FDA for Zipsor, indicated for mild to moderate acute pain. Zipsor is an immediate release liquid-filled soft gelatin capsule containing 25 mg of diclofenac potassium, for oral administration.   

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.